EBC 《５７金錢爆》藥神變股神？ 抗癌藥真人真事搬大螢幕- 朱紀中2018.0706
Gleevec on Wikipedia:
Imatinib, sold under the brand names Gleevec (格列宁) among others, is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+) and certain types of gastrointestinal stromal tumors (GIST), systemic mastocytosis, and myelodysplastic syndrome. It is taken by mouth.
Imatinib was approved for medical use in the United States in 2001. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 1,386.49 to 19,162.50 USD a year. In the United States a typical dose for a year has a wholesale cost of $84,408.78, while in the United Kingdom the NHS was paying about £20,980 ($26898) in 2016. A generic version became available in the UK as of 2017.
Iberia Passage 英國 - 佛羅里達
Old Hong Kong 老香港
The Beauty of China 中国之美
Transpacific Voyage 上海- 阿拉斯加